| Jump to: | Authorized Access | | | Attribution | | | Authorized Requests |
- Study Description
-
Important Links and Information
-
Request access via Authorized Access
- Instructions for requestors
- Data Use Certification (DUC) Agreement
- Talking Glossary of Genetic Terms
Generalized vitiligo is an autoimmune disease in which melanocyte loss results in patchy depigmentation of skin and hair. For this GWAS of generalized vitiligo, 579,146 SNPs were genotyped in 1514 generalized vitiligo cases of European-derived white (CEU) ancestry versus data from 2813 "public" CEU controls. 49 strongly associated SNPs from the first phase of the GWAS were then tested in two replication studies, one comparing 677 independent cases and 1106 CEU controls, and the other a family-based analysis of 204 CEU simplex generalized vitiligo trios and 310 CEU multiplex families. Overall, significant association of generalized vitiligo was detected for SNPs in several genes previously associated with other autoimmune diseases, including MHC class I (P = 9.05 x 10-23) and class II (P = 4.50 x 10-34) loci, PTPN22 (P = 1.31 x 10-7), LPP (P = 1.01 x 10-11), IL2RA (P = 2.78 x 10-9), UBASH3A (P = 1.26 x 10-9), and C1QTNF6 (P = 2.21 x 10-16). Association was also detected for SNPs in two novel immune-related loci, RERE (P = 7.07 x 10-15), GZMB (P = 3.44 x 10-8), and in a locus that may mediate melanocyte target cell specificity, TYR (P = 1.60 x 10-18) encoding tyrosinase. These findings thus demonstrate association between generalized vitiligo and multiple genes, some associated with other autoimmune diseases and others that may mediate target-cell specificity, and suggest a possible inverse relationship between susceptibility to vitiligo versus melanoma.
- Study Design:
- Case-Control
- Study Type:
- Case-Control
- Multiplex Families
- Parent-Offspring Trios
- dbGaP estimated ancestry using GRAF-pop
- Total number of consented subjects: 1392
- Subject Sample Telemetry Report (SSTR)
-
Request access via Authorized Access
- Authorized Access
- Publicly Available Data
- Study Inclusion/Exclusion Criteria
Cases:
- Inclusion: CEU: must meet strict clinical diagnostic criteria for generalized vitiligo
- Exclusion: CEU: must not have any form of congenital hypopigmentation, segmental vitiligo, any questionable diagnosis
Controls:
- Inclusion: CEU
- Exclusion: Vitiligo or any hypopigmentation disorder, any known relative with vitiligo
Trios:
- Case plus parents (affected or not affected)
Multiplex families:
- Case plus at least one other affected relative (not parent), plus as many connecting relatives as possible
- Molecular Data
-
Type Source Platform Number of Oligos/SNPs SNP Batch Id Comment Whole Genome Genotyping Illumina Human660W-Quad_v1_A 592839 1048965 - Selected Publications
- Diseases/Traits Related to Study (MeSH terms)
-
- Primary Phenotype: Vitiligo
- Authorized Data Access Requests
- Study Attribution
-
-
Principal Investigator
- Richard A. Spritz, MD. University of Colorado Denver, Aurora, CO, USA.
-
Institute
- Human Medical Genetics and Genomics Program.
-
Funding Source
- R01AR056292. National Institutes of Health, Bethesda, MD, USA.
-
Principal Investigator